Watch List for Investors: Siliconware Precision Industries Co. (NASDAQ:SPIL), Cumberland Pharmaceuticals (NASDAQ:CPIX), Asanko Gold (NYSEMKT:AKG)

Everyday Health, Inc. (NYSE:EVDY) shares moved down -1.11% in last trading session and ended the day at $4.44. EVDY Gross Margin is 72.10% and its has a return on assets of 0.60%. Everyday Health, Inc. (NYSE:EVDY) quarterly performance is -21.83%.

Everyday Health, Inc. (NSYE:EVDY), a leading provider of digital health marketing and communications solutions, will announce its financial results for the fourth quarter and fiscal year ended December 31, 2015 on Tuesday, March 1, 2016 after the market close.

Eagle Bulk Shipping Inc. (NASDAQ:EGLE) ended the last trading day at $0.71. Company weekly volatility is calculated as 23.57% and price to cash ratio as 1.03. Eagle Bulk Shipping Inc. (NASDAQ:EGLE) showed a weekly performance of 61.36%.

On February 9, 2016, Eagle Bulk Shipping Inc. (NASDAQ:EGLE), the Guarantors, the Specified Lenders and the Agent and Security Trustee entered into Limited Waiver to the Loan Agreement and Amendment No. 2 to Forbearance and Standstill Agreement (“Amendment No. 2”). As a condition to the effectiveness of Amendment No. 2, the Company made the quarterly payment installment to the Lenders that was due on January 15, 2016 in the amount of $3,906,250, which payment served to cure the related event of default under the Loan Agreement.

On 18 February, Siliconware Precision Industries Co. Ltd. (NASDAQ:SPIL) shares moved down -0.51% and was closed at $7.79. SPIL EPS growth in last 5 year was 4.70%. Siliconware Precision Industries Co. Ltd. (NASDAQ:SPIL) year to date (YTD) performance is 0.52%.

Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) shares advanced 2.00% in last trading session and ended the day at $4.58. CPIX Gross Margin is 86.50% and its has a return on assets of 1.20%. Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) quarterly performance is -20.21%.

O 10 February, Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced the publication of an open label multicenter study adding to the growing body of literature that supports Vaprisol® (conivaptan) Injection. The study evaluated both 20 and 40 mg/day doses of conivaptan in hyponatremic patients. The new publication is currently available as open access articles in the journal Drug Design, Development and Therapy.

Asanko Gold Inc. (NYSEMKT:AKG) caters to the Basic Materials space. Its weekly performance is 15.29%. On the last day of trading company shares ended up at $1.96. Asanko Gold Inc. (NYSEMKT:AKG) distance from 50-day simple moving average (SMA50) is 29.65%.

Asanko Gold Inc (NYSEMKT:AKG) had its price target decreased by equities research analysts at CIBC from $3.00 to $2.85 in a research report issued to clients and investors on Tuesday, AnalystRatingsNetwork.com reports. CIBC’s target price would suggest a potential upside of 19.75% from the company’s previous close.